Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics Gets $510M to Screen Protein Interaction Inhibitors

NEW YORK (GenomeWeb News) – Hybrigenics has received €400,000 ($510.4 million) to screen inhibitors of protein interaction under a collaboration with the Masterswitch European union research project.

Hybrigenics will use its protein interaction technologies and expertise in the field of chronic inflammatory diseases, the Paris-based firm said today. It will develop a high-throughput assay and screen its library of 100,000 compounds and its collection of around 2,000 natural substances. The goal is to identify small-molecule inhibitors of a therapeutically relevant protein interaction, said Hybrigenics.

The firm will receive the funding over the first two years of a five-year collaboration.

The Masterswitch project is part of the EU's 7th Framework Programme and includes a consortia of 16 participants. The primary objective of the project is to develop new treatments for chronic inflammatory diseases.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.